Cerebral Amyloid Angiopathy research hub

A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy

This study is looking at a new medicine called ALN-APP for a condition called Cerebral Amyloid Angiopathy (CAA). It aims to see how well ALN-APP works to slow down CAA and if it's safe. Participants will either receive the new medicine or a dummy treatment.